MRK

2026Q1BMO

Merck & Company Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-04-30 · Fiscal end 2026-03-31 · Features as of 2026-04-29

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-1.47
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.0%
IV front—
P/C full—
P/C front—
Features as of2026-04-29

Run-up

Close—
Ret 5d-1.7%
Ret 10d-5.9%
Ret 20d-7.8%
Ret 30d-4.2%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-1.28Beat
Estimated EPS-1.47
Actual revenue
16.3B
Surprise %+12.9%
Beat / missBeat
Beat streak 44
Beat streak 86

Reaction

1-day stock reaction-0.1%
Implied vs actual

Implied 2.0%Actual 1.5%

Gap reaction-1.5%
Day result-1.6%
Next-day upNo
Realized / IV0.72×

Post tape

Post 5d+2.9%
Post 10d+3.9%
Post volume17.1M
Vol ×10d1.79×
Vol ×20d1.92×
Post range3.3%